• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

COVID player and Pfizer-partnered Valneva eyes $100M Nasdaq IPO

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 12, 2021 at 11:42: PM
via French biotech Valneva, which has developed a lineup of traveler vaccines and is starting a late-stage COVID vax effort, is seeking to level up to the Nasdaq with a $100 million IPO.

article source
 




Top Bottom
Back
Quote